Full-Time

Medical Director

Oncology

Posted on 4/18/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation technologies for diseases

Biotechnology

Senior

Menlo Park, CA, USA

Requirements
  • MD required, board eligible or certified in oncology /hematology
  • 2+ years’ experience in a pharmaceutical environment
  • Relevant clinical research experience in academic and industry settings
Responsibilities
  • Act as a clinical expert for both internal Company team members and external contacts related to the assigned therapeutic programs
  • Provide clinical and scientific leadership including training and ongoing input, to members of the development and product core teams on issues related to the therapeutic field
  • Provide medical oversight for the company's operational staff, CROs, and clinical trial sites in areas related to the oncology programs
  • Design the clinical development plan for indications relevant to assigned molecule programs and support the assessment of the development plans through the cross-functional product core team
  • Design, develop, and implement clinical studies for the applicable drug candidate, from Phase I through Phase III
  • Establish relationships with external experts in the scientific oncology areas, including principal investigators and opinion leaders, to facilitate scientific excellence in clinical trial research
  • Establish and approve scientific methods for the design and implementation of applicable clinical protocols, data collection systems, and final reports
  • Participate in the writing and review of clinical protocols, investigator brochures, clinical study reports, publications, and other documents
  • Deliver timely and high-quality clinical data
  • Provide medical oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee
  • Participate in appropriate regulatory discussion and activities, including the filing of IND’s, CTXs, NDA/MAAs, throughout the development cycle
  • Participate in clinical study report conceptualization, development and writing for global regulatory submissions

Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

10%

1 year growth

19%

2 year growth

42%